Khairkhahan, Alexander (Palo Alto, CA, US)
Nikolic, Serjan D. (Los Altos, CA, US)
Radovancevic, Branislav (Houston, TX, US)
Sharkey, Hugh R. (Palomar Park, CA, US)

Plaque It! Sponsored by: Flash of Genius

10/754182

07/15/2008

01/09/2004

Images are available in PDF form when logged in. To view PDFs, Login  or  Create Account (Free!)

Click for automatic bibliography generation

CardioKinetix, Inc. (Redwood City, CA, US)

600/37

600/16

A61F2/00

600/37, 600/16

3874388	SHUNT DEFECT CLOSURE SYSTEM	April, 1975	King et al.
4007743	Opening mechanism for umbrella-like intravascular shunt defect closure device	February, 1977	Blake
4425908	Blood clot filter	January, 1984	Simon
4619246	Collapsible filter basket	October, 1986	Molgaard-Nielsen et al.
4710192	Diaphragm and method for occlusion of the descending thoracic aorta	December, 1987	Liotta et al.
4832055	Mechanically locking blood clot filter	May, 1989	Palestrant
4917089	Buttoned device for the transvenous occlusion of intracardiac defects	April, 1990	Sideris
5104399	Artificial graft and implantation method	April, 1992	Lazarus
5192301	Closing plug of a defect for medical use and a closing plug device utilizing it	March, 1993	Kamiya et al.
5192314	Synthetic intraventricular implants and method of inserting	March, 1993	Daskalakis et al.
5375612	Possibly absorbable blood filter	December, 1994	Cottenceau et al.
5385156	Diagnostic and treatment method for cardiac rupture and apparatus for performing the same	January, 1995	Oliva
5425744	Occluder for repair of cardiac and vascular defects	June, 1995	Fagan et al.
5433727	Centering buttoned device for the occlusion of large defects for occluding	July, 1995	Sideris
5451235	Occluder and method for repair of cardiac and vascular defects	September, 1995	Lock et al.
5496277	Radially expandable body implantable device	March, 1996	Termin et al.
5527337	Bioabsorbable stent and method of making the same	June, 1996	Stack et al.
5527338	Intravascular device	June, 1996	Purdy
5549621	Apparatus and method for performing vertical banded gastroplasty	August, 1996	Bessler et al.
5578069	Electrode deployment mechanism and method using artificial muscle	November, 1996	Miner, II
5634936	Device for closing a septal defect	June, 1997	Linden et al.
5634942	Assembly comprising a blood filter for temporary or definitive use and a device for implanting it	June, 1997	Chevillon et al.
5702343	Cardiac reinforcement device	December, 1997	Alferness
5709707	Self-centering umbrella-type septal closure device	January, 1998	Lock et al.
5791231	Surgical robotic system and hydraulic actuator therefor	August, 1998	Cohn et al.
5797849	Method for carrying out a medical procedure using a three-dimensional tracking and imaging system	August, 1998	Vesely et al.
5797960	Method and apparatus for thoracoscopic intracardiac procedures	August, 1998	Stevens et al.
5829447	Method and apparatus for thoracoscopic intracardiac procedures	November, 1998	Stevens et al.
5833698	Anastomosis instrument and method	November, 1998	Hinchliffe et al.
5836968	Removable embolus blood clot filter	November, 1998	Simon et al.
5843170	Apparatus and method for performing aneurysm repair	December, 1998	Ahn
5861003	Apparatus and method for occluding a defect or aperture within body surface	January, 1999	Latson et al.
5865730	Tissue stabilization device for use during surgery having remotely actuated feet	February, 1999	Fox et al.
5865791	Atrial appendage stasis reduction procedure and devices	February, 1999	Whayne et al.
5871017	Relative motion cancelling platform for surgery	February, 1999	Mayer
5875782	Methods and devices for minimally invasive coronary artery revascularization on a beating heart without cardiopulmonary bypass	March, 1999	Ferrari et al.
5876325	Surgical manipulation system	March, 1999	Mizuno et al.
5876449	Stent for the transluminal implantation in hollow organs	March, 1999	Starck et al.
5879366	Self-expanding defect closure device and method of making and using	March, 1999	Shaw et al.
5882340	Penetrating instrument having an expandable anchoring portion for triggering protrusion of a safety member and/or retraction of a penetrating member	March, 1999	Yoon
5910150	Apparatus for performing surgery	June, 1999	Saadat
5916145	Device and method of using a surgical assembly with mesh sheath	June, 1999	Chu et al.
5924424	Method and apparatus for thoracoscopic intracardiac procedures	July, 1999	Stevens et al.
5925076	Appliance to be implanted, method of collapsing the appliance to be implanted and method of using the appliance to be implanted	July, 1999	Inoue
5928260	Removable occlusion system for aneurysm neck	July, 1999	Chin et al.
5961440	Heart wall tension reduction apparatus and method	October, 1999	Schweich, Jr. et al.
5961539	Method and apparatus for sizing, stabilizing and/or reducing the circumference of an anatomical structure	October, 1999	Northrup, III et al.
5984917	Device and method for remote insertion of a closed loop	November, 1999	Fleischman et al.
6024096	Anterior segment ventricular restoration apparatus and method	February, 2000	Buckberg
6024756	Method of reversibly closing a septal defect	February, 2000	Huebsch et al.
6045497	Heart wall tension reduction apparatus and method	April, 2000	Schweich et al.
6059715	Heart wall tension reduction apparatus	May, 2000	Schweich et al.
6076013	Apparatus and methods for treating congestive heart failure	June, 2000	Brennan et al.
6077214	Stress reduction apparatus and method	June, 2000	Mortier et al.
6077218	Cardiac reinforcement device	June, 2000	Alferness
6093199	Intra-luminal device for treatment of body cavities and lumens and method of use	July, 2000	Brown et al.
6095968	Reinforcement device	August, 2000	Snyders
6096347	Myocardial graft constructs	August, 2000	Geddes et al.
6099832	Transplants for myocardial scars	August, 2000	Mickle et al.
6102887	Catheter drug delivery system and method for use	August, 2000	Altman
6125852	Minimally-invasive devices and methods for treatment of congestive heart failure	October, 2000	Stevens et al.
6132438	Devices for installing stasis reducing means in body tissue	October, 2000	Fleischman et al.
6152144	Method and device for left atrial appendage occlusion	November, 2000	Lesh et al.
6161543	Methods of epicardial ablation for creating a lesion around the pulmonary veins	December, 2000	Cox et al.
6193731	Laparoscopic insertion and deployment device	February, 2001	Oppelt et al.
6221092	Closure device for transcatheter operations and catheter assembly therefor	April, 2001	Koike et al.
6231561	Method and apparatus for closing a body lumen	May, 2001	Frazier et al.
6258021	Intrapericardial assist method	July, 2001	Wilk
6267772	Implantable prosthesis	July, 2001	Mulhauser et al.
6290674	Method and apparatus for closing intracardiac septal defects	September, 2001	Roue et al.
6312446	Apparatus and method for closing a septal defect	November, 2001	Huebsch et al.
6328727	Transluminal anastomosis method and apparatus	December, 2001	Frazier et al.
6334864	Alignment member for delivering a non-symmetric device with a predefined orientation	January, 2002	Amplatz et al.
6343605	Percutaneous transluminal myocardial implantation device and method	February, 2002	Lafontaine
6348068	Multi-filament valve stent for a cardisc valvular prosthesis	February, 2002	Campbell et al.
6355052	Device for closure of body defect openings	March, 2002	Neuss et al.
6360749	Modification of properties and geometry of heart tissue to influence heart function	March, 2002	Jayaraman
6364896	Compliant framework and methods of use	April, 2002	Addis
6387042	Apparatus aiding physiologic systolic and diastolic dynamics of cardiac cavities	May, 2002	Herrero
6406420	Methods and devices for improving cardiac function in hearts	June, 2002	McCarthy et al.
6419669	Method and apparatus for patching a tissue opening	July, 2002	Frazier et al.
6436088	Method and apparatus for closing a subcutaneous tissue opening	August, 2002	Frazier et al.
6450171	Anterior and inferior segment ventricular restoration apparatus and method	September, 2002	Buckberg et al.
6482228	Percutaneous aortic valve replacement	November, 2002	Norred
6506204	Method and apparatus for occluding aneurysms	January, 2003	Mazzocchi
6511496	Embolic protection device for use in interventional procedures	January, 2003	Huter et al.
6537198	Splint assembly for improving cardiac function in hearts, and method for implanting the splint assembly	March, 2003	Vidlund et al.
6551303	Barrier device for ostium of left atrial appendage	April, 2003	Van Tassel et al.
6592608	Bioabsorbable sealant	July, 2003	Fisher et al.
6652555	Barrier device for covering the ostium of left atrial appendage	November, 2003	VanTassel et al.
6685627	Modification of properties and geometry of heart tissue to influence heart function	February, 2004	Jayaraman
6852076	Method for improving cardiac function	February, 2005	Nikolic et al.
20010014800	Method of reducing the volume of the heart	August, 2001	Frazier et al.
20020019580	Expandable cardiac harness for treating congestive heart failure	February, 2002	Lau et al.
20020026092	Ventricular restoration patch	February, 2002	Buckberg et al.
20020028981	Expandable cardiac harness for treating congestive heart failure	March, 2002	Lau et al.
20020032481	Heart valve prosthesis and sutureless implantation of a heart valve prosthesis	March, 2002	Gabbay
20020055767	Over-the-wire interlock attachment/detachment mechanism	May, 2002	Forde et al.
20020055775	FLEXIBLE HEART VALVE	May, 2002	Carpentier et al.
20020161394	Aortic filter catheter	October, 2002	Macoviak et al.
20020169359	Methods and devices for improving cardiac function in hearts	November, 2002	McCarthy et al.
20020169360	Surgical procedures and devices for increasing cardiac output of the heart	November, 2002	Taylor et al.
20020188170	Prevention of myocardial infarction induced ventricular expansion and remodeling	December, 2002	Santamore et al.
20030050682	Device for improving cardiac function	March, 2003	Sharkey et al.
20030050685	Method for improving cardiac function	March, 2003	Nikolic et al.
20030105384	Method of improving cardiac function using a porous membrane	June, 2003	Sharkey et al.
20030109770	Device with a porous membrane for improving cardiac function	June, 2003	Sharkey et al.
20030120337	Barrier device for ostium of left atrial appendage	June, 2003	Van Tassel et al.
20030149333	Cardiac reinforcement device	August, 2003	Alferness
20030220667	Method of containing embolic material in the left atrial appendage	November, 2003	Van Der Burg et al.
20040002626	In-vivo method and device for improving diastolic function of the left ventricle	January, 2004	Feld et al.
20040064014	Devices and methods for assisting natural heart function	April, 2004	Melvin et al.
20040260331	Beta titanium embolic protection frame and guide wire	December, 2004	D'Aquanni et al.
20040267378	Semi-stationary balloon in the gastric antrum provided with connecting an anchoring rod for inducing weight reduction in human beings	December, 2004	Gazi et al.
20050015109	Methods and devices for altering blood flow through the left ventricle	January, 2005	Lichtenstein	606/200
20050113861	Left atrial appendage closure device	May, 2005	Corcoran et al.
20050177180	Devices, systems, and methods for supporting tissue and/or structures within a hollow body organ	August, 2005	Kaganov et al.
20050197716	Inflatable ventricular partitioning device	September, 2005	Sharkey et al.
20050216052	Method of forming medical devices; intravascular occlusion devices	September, 2005	Mazzocchi et al.
20060014998	Multiple partitioning devices for heart treatment	January, 2006	Sharkey et al.
20060030881	Ventricular partitioning device	February, 2006	Sharkey et al.

WO/2000/027292	May, 2000			METHOD AND DEVICE FOR LEFT ATRIAL APPENDAGE OCCLUSION
WO/2001/030266	May, 2001			FILTER APPARATUS FOR OSTIUM OF LEFT ATRIAL APPENDAGE
WO/2001/078625	October, 2001			ENDOVENTRICULAR DEVICE FOR THE TREATMENT AND CORRECTION OF CARDIOMYOPATHIES
WO/2002/030335	April, 2002			ENDOVASCULAR SPLINTING DEVICES
WO/2002/071977	September, 2002			ATRIAL FILTER IMPLANTS
WO/2003/007778	January, 2003			IN-VIVO METHOD AND DEVICE FOR IMPROVING DIASTOLIC FUNCTION OF THE LEFT VENTRICLE
WO/2004/012629	February, 2004			A DEVICE FOR IMPROVING CARDIAC FUNCTION
WO/2004/100803	November, 2004			A SYSTEM FOR IMPROVING CARDIAC FUNCTION
WO/2005/007031	January, 2005			METHODS AND DEVICES FOR ALTERING BLOOD FLOW THROUGH THE LEFT VENTRICLE

International Search Report and Written Opinion for PCT/US2004/014782 mailed Sep. 21, 2004.
Tetsuji Kawata et al., “Systolic and Diastolic Function After Patch Reconstruction of Left Ventricular Aneurysms”, Ann. Thorac. Surg. 59, pp. 403-407, 1995.
Vincent Dor, “The Treatment of Refractory Ischemic Ventricular Tachycardia by Endoventricular Patch Plasty Reconstruction of the Left Ventricle”, Seminars in Thoracic and Cardiovascular Surgery, vol. 9, No. 2, pp. 146-155, Apr. 1997.
Daniel Giorgio Di Mattia et al., “Surgical treatment of left ventricular post-infarction aneurysm with endoventriculoplasty: late clinical and functional results”, European Journal of Cardio-thoracic Surgery 15, pp. 413-419, 1999.
T Katsumata et al., “An objective appraisal of partial left ventriculectomy for heart failure”, Journal of Congestive Heart Failure and Circular Support, pp. 97-106, 1999.
Vincent Dor, “Surgery for left ventricular aneurysm”, Current Opinion in Cardiology, Current Science, pp. 773-780, 1990.
Vincent Dor et al., “Ventricular remodeling in coronary artery disease”, Current Opinion in Cardiology, Rapid Science Publishers, pp. 533-537, 1997.
AGA Medical Corporation, www.amplatzer.com/products, “The Muscular VSD Occluder” and “The Septal Occluder” device descriptions, Apr. 3, 2002.
Gore Medical, www.goremedical.com, “Helex Septal Occluder” product description, Apr. 3, 2002.
International Search Report and Written Opinion for PCT/US2005/000264 mailed Apr. 26, 2005.
Khairkhahan, et al., U.S. Appl. No. 10/436,959, entitled “System for improving cardiac function,” filed May 12, 2003.
Khairkhahan, et al., U.S. Appl. No. 11/151,164, entitled “Peripheral seal for a ventricular partitioning device,” filed Jun. 10, 2005.
Sharkey, et al., U.S. Appl. No. 11/199,633, entitled “Method for treating myocardial rupture,” filed Aug. 9, 2005.
Khairkhahan, et al; U.S. Appl. No. 11/801,075, entitled “System for improving cardiac function,” filed May 7, 2007.
Khairkhahan et al; U.S. Appl. No. 11/800,998, entitled “System for improving cardiac function,” filed May 7, 2007.
Nikolic et al; U.S. Appl. No. 11/640,469, entitled “Cardiac device and methods of use thereof,” filed Dec. 14, 2006.
Khairkhahan et al; U.S. Appl. No. 11/860,438 entitled “Laminar ventricular partitioning device,” filed Sep. 24, 2007.

Evanisko, George R.

Shay Glenn LLP

What is claimed is:

1. A partitioning apparatus for a patient's heart chamber to improve cardiac ejection fraction, comprising: a. a central hub component; b. an expandable frame component having a plurality of ribs with free proximal ends and distal ends secured to the central hub; c. a membrane component secured to the expandable frame ribs which limits the radial expansion of the free proximal ends of the ribs to less than about 90° from a center line axis, wherein the membrane component is configured to partition the patient's ventricle and withstand repeated ventricular contractions; and d. a support component extending from a distal side of the frame comprising an elongated stem and a bumper, wherein the bumper is configured to non-traumatically engage a region of the patient's ventricular wall defining in part the heart chamber being partitioned.

2. The partitioning apparatus of claim 1 wherein the bumper has at least one resilient member to non-traumatically engage the region of the patient's ventricular wall.

3. The partitioning apparatus of claim 2 wherein the at least one resilient member has a J-shape.

4. The partitioning apparatus of claim 2 wherein the bumper has a helical coil shape.

5. The partitioning apparatus of claim 1 wherein the support component is an inflatable member.

6. The partitioning apparatus of claim 1 wherein the membrane component is secured to the proximal side of the ribs.

7. The partitioning apparatus of claim 1 wherein the membrane component is secured to the distal side of the ribs.

8. The device of claim 1, wherein the membrane component in the expanded configuration has a radial dimension from about 50 mm to about 100 mm from the center line axis.

9. The device of claim 1, wherein the stem extends distally along the center line axis.

10. The device of claim 1, wherein the bumper extends in a plane substantially perpendicular to the stem.

11. The device of claim 1, wherein the stem extends between about 5 mm and about 50 mm from the distal side of the expandable frame component.

12. The device of claim 1, wherein the stem extends between about 15 mm and about 35 mm from the distal side of the expandable frame component.

13. The device of claim 1, wherein the bumper comprises a loop.

14. The device of claim 1, wherein the stem comprises an internal lumen and one or more ports through which a diagnostic or therapeutic agent may be delivered.

15. A device for treating a patient with CHF by partitioning a heart chamber thereof, comprising: a. a central hub component; b. an expandable frame component having a plurality of ribs with distal ends secured to the central hub component and free proximal ends and distal ends secured to the central hub component; c. a membrane component secured to the ribs of the expandable frame, wherein the membrane component is configured to partition the patient's ventricle and withstand repeated ventricular contractions; and d. a support component comprising an elongated stem and a bumper, wherein the stem extends from the distal side of the expandable frame component, and wherein the bumper extends in a plane substantially perpendicular to the stem and is configured to space the expandable frame component from a ventricular wall and has sufficient give to provide non-traumatic engagement with a weakened portion of the ventricular wall.

16. The device of claim 15 wherein the ribs of the expandable frame component limit the radial expansion of the free proximal ends of the ribs to less than 90° .

17. The device of claim 15 wherein the support component has a proximal end secured to the central hub component and the bumper is secured at the distal end of the stem.

18. The device of claim 17 wherein the flexible bumper of the support component has a J-shape.

19. The device of claim 17 wherein the distal end of the support component has a plurality of J-shape bumpers.

20. The device of claim 15, wherein the membrane component in the expanded configuration has a radial dimension from about 50 mm to about 100 mm from the center line axis.

21. The device of claim 15, wherein the stem extends distally along the center line axis.

22. The device of claim 15, wherein the stem extends between about 5 mm and about 50 mm from the distal side of the expandable frame component.

23. The device of claim 15, wherein the stem extends between about 15 mm and about 35 mm from the distal side of the expandable frame component.

24. The device of claim 15, wherein the bumper extends in plane substantially perpendicularly from the distal end of the center line axis.

25. The device of claim 15, wherein the bumper comprises a loop.

26. The device of claim 15, wherein the stem comprises an internal lumen and one or more ports through which a diagnostic or therapeutic agent may be delivered.

27. A device for treating a patient with CHF by partitioning a heart chamber thereof, comprising: a. a central hub; b. a frame having a plurality of ribs with distal ends secured to the central hub and free proximal ends and distal ends secured to the central hub; c. a membrane secured to the ribs of the frame, wherein the membrane is configured to partition the patient's ventricle and withstand repeated ventricular contractions; and d. a support which extends from the distal side of the expandable frame, which is configured to space the expandable frame from a ventricular wall and which has sufficient give to provide non-traumatic engagement with a weakened portion of the ventricular wall, wherein the support comprises an elongated stem and a curved bumper, wherein the elongate stem extends distally along a center line axis, and the bumper extends in a plane substantially perpendicular to the stem.

FIELD OF THE INVENTION

The present invention relates generally to the field of treating congestive heart failure and more specifically, to a device and method for partitioning a patient's heart chamber and a system for delivering the treatment device.

BACKGROUND OF THE INVENTION

Congestive heart failure (CHF) is characterized by a progressive enlargement of the heart, particularly the left ventricle and is a major cause of death and disability in the United States. Approximately 500,000 cases occur annually in the U.S. alone. As the patient's heart enlarges, it cannot efficiently pump blood forward with each heart beat. In time, the heart becomes so enlarged the heart cannot adequately supply blood to the body. Even in healthy hearts only a certain percentage of the blood in a patient's left ventricle is pumped out or ejected from the chamber during each stroke of the heart. The pumped percentage, commonly referred to as the “ejection fraction”, is typically about sixty percent for a healthy heart. A patient with congestive heart failure can have an ejection fraction of less than 40% and sometimes lower. As a result of the low ejection fraction, a patient With congestive heart failure is fatigued, unable to perform even simple tasks requiring exertion and experiences pain and discomfort. Further, as the heart enlarges, the internal heart valves such as the mitral valve, cannot adequately close. An incompetent mitral valve allows regurgitation of blood from the left ventricle back into the left atrium, further reducing the heart's ability to pump blood forewardly.

Congestive heart failure can result from a variety of conditions, including viral infections, incompetent heart valves (e.g. mitral valve), ischemic conditions in the heart wall or a combination of these conditions. Prolonged ischemia and occlusion of coronary arteries can result in myocardial tissue in the ventricular wall dying and becoming scar tissue. Once the myocardial tissue dies, it is less contractile (sometimes non-contractile) and no longer contributes to the pumping action of the heart. It is referred to as hypokinetic. As the disease progresses, a local area of compromised myocardium may bulge out during the heart contractions, further decreasing the heart's ability to pump blood and further reducing the ejection fraction. In this instance, the heart wall is referred to as dyskinetic or akinetic. The dyskinetic region of the heart wall may stretch and eventually form an aneurysmic bulge.

Patients suffering from congestive heart failure are commonly grouped into four classes, Classes I, II, III and IV. In the early stages, Classes I and II, drug therapy is presently the most commonly prescribed treatment. Drug therapy typically treats the symptoms of the disease and may slow the progression of the disease, but it can not cure the disease. Presently, the only permanent treatment for congestive heart disease is heart transplantation, but heart transplant procedures are very risky, extremely invasive and expensive and are performed on a small percentage of patients. Many patient's do not qualify for heart transplant for failure to meet any one of a number of qualifying criteria, and, Furthermore, there are not enough hearts available for transplant to meet the needs of CHF patients who do qualify.

Substantial effort has been made to find alternative treatments for congestive heart disease. For example, surgical procedures have been developed to dissect and remove weakened portions of the ventricular wall in order to reduce heart volume. This procedure is highly invasive, risky and expensive and is commonly only done in conjunction with other procedures (such as heart valve replacement or coronary artery by-pass graft). Additionally, the surgical treatment is usually limited to Class IV patients and, accordingly, is not an option for patients facing ineffective drug treatment prior to Class IV. Finally, if the procedure fails, emergency heart transplant is the only presently available option.

Other efforts to treat CHF include the use of an elastic support, such as an artificial elastic sock placed around the heart to prevent further deleterious remodeling.

Additionally, mechanical assist devices have been developed as intermediate procedures for treating congestive heart disease. Such devices include left ventricular assist devices and total artificial hearts. A left ventricular assist device includes a mechanical pump for increasing blood flow from the left ventricle into the aorta. Total artificial heart devices, such as the Jarvik heart, are usually used only as temporary measures while a patient awaits a donor heart for transplant.

Recently, improvements have been made in treating patient's with CHF by implanting pacing leads in both sides of the heart in order to coordinate the contraction of both ventricles of the heart. This technique has been shown to improve hemodynamic performance and can result in increased ejection fraction from the right ventricle to the patient's lungs and the ejection fraction from the left ventricle to the patient's aorta. While this procedure has been found to be successful in providing some relief from CHF symtoms and slowed the progression of the disease, it has not been able to stop the disease.

SUMMARY OF INVENTION

The present invention is directed to a ventricular partitioning device and method of employing the device in the treatment of a patient with congestive heart failure. Specifically, the ventricular chamber of the CHF patient is partitioned by the device so as to reduce its total volume and to reduce the stress applied to the heart and, as a result, improve the ejection fraction thereof.

A ventricular partitioning device embodying features of the invention has a reinforced membrane component, preferably self expanding, which is configured to partition the patient's ventricular heart chamber into a main productive portion and a secondary non-productive portion, and a support or spacing component extending from the distal side of the reinforced membrane for non-traumatically engaging a region of the patient's ventricular wall defining in part the secondary non-productive portion to space a central portion of the reinforced membrane from the heart wall. The partitioning device preferably includes a centrally located hub secured to the reinforced membrane. The partitioning membrane of the device may be reinforced by a radially expandable frame component formed of a plurality of ribs.

The ribs of the expandable frame have distal ends secured to the central hub, preferably secured to facilitate abduction of the free proximal ends of the ribs away from a centerline axis. The distal ends of the ribs may be pivotally mounted or formed of material such as superelastic NiTi alloy which allow for compressing the ribs into a contracted configuration and when released allow for their self expansion. The ribs also have free proximal ends configured to engage and preferably penetrate the tissue of the heart wall so as to secure the peripheral edge of the membrane to the heart wall and fix the position of the membrane with respect thereto. The free proximal ends of the ribs may have tissue penetrating tips such as barbs or hooks. The partitioning membrane is secured to the ribs of the expandable frame, preferably on the proximal or pressure side of the expandable frame.

The supporting component or stem of the device has a length configured to extend to the heart wall (typically about 5 mm to about 50 mm, preferably about 15 to about 35 mm), to support and space the membrane from the heart wall. While only one supporting component or stem is described herein, a plurality of such components may be utilized. The supporting component or stem may have at least one inner lumen extending therein for delivery of therapeutic or diagnostic agents through the ports provided along the length thereof. The stem is provided with one or more flexible bumper-type elements on its distal end to non-traumatically engage the weakened ventricular wall and maintain the reinforced membrane, preferably the central portion thereof, spaced a desired distance from the weakened ventricular wall.

The partitioning membrane in the expanded configuration has radial dimensions from about 10 to about 160 mm, preferably about 50 to about 100 mm, as measured from the center line axis.

The partitioning device may be delivered percutaneously or intraoperatively. It is relatively easy to install and provides substantial improvement in the ejection fraction of the patient's heart chamber. These and other advantages of the invention will become more apparent from the following detailed description of the invention and the accompanying exemplary drawings.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a schematic perspective view of a ventricular partitioning device embodying features of the invention.

FIG. 2 is an elevational view of a delivery system for the partitioning device shown in FIG. 1

FIG. 3 is an enlarged view of the encircled region 3 - 3 shown in FIG. 2.

FIG. 4 is a simplified view with parts removed similar to that shown in FIG. 3 with the delivery catheter connected to the partitioning device.

FIG. 5 is an end view of the hub which is secured in the proximal end of the stem of the partitioning device shown in FIG. 1.

FIG. 6 is a schematic view of a patient's left ventricular chamber illustrating the partitioning device shown in FIG. 1 disposed within the chamber separating a working portion of the chamber from an non-working portion of the chamber.

FIG. 7 is a schematic perspective view of an alternative design embodying features of the invention with a pair of bumper elements on the distal end of the stem of the partitioning device.

FIG. 8 is a schematic perspective view of another alternative design embodying features of the invention with three bumper elements on the distal end of the stem of the partitioning device.

FIG. 9 is a schematic perspective view of another alternative design embodying features of the invention with four bumper elements on the distal end of the stem of the partitioning device.

FIG. 10 is a schematic perspective view of a fourth alternative design embodying features of the invention with a plurality of bumper elements on the distal end of the stem of the device provided with hooks which fix the end to the interior surface of the patient's ventricular wall.

FIG. 11 is a schematic perspective view of another alternative design embodying features of the invention with a membrane underlying a plurality of bumper elements on the distal end of the stem of the partitioning device.

FIG. 12 is a schematic perspective view of another alternative design embodying features of the invention with a helical coil bumper element on the distal end of the stem of the partitioning device.

FIG. 13 is a schematic perspective view of yet another alternative design embodying features of the invention with an inflatable balloon secured to the underside of the partitioning device to space and support the partitioning device from the heart wall.

DETAILED DESCRIPTION OF EMBODIMENTS OF THE INVENTION

FIGS. 1-5 illustrate a partitioning device 10 which embodies features of the invention and which includes a partitioning membrane 11 , a stem 12 and a radially expandable reinforcing frame 13 formed of a plurality of ribs 14 . Preferably the membrane 11 is secured to the proximal or pressure side of the frame 13 as shown in FIG. 1. The distal ends 15 of the ribs 14 are secured to the central hub 16 and the proximal ends 17 of the ribs 14 are unsecured and are configured to radially extend away from a center line axis 18 which extends through the hub 16 . Radial expansion of the free proximal ends 17 unfurls the membrane 11 secured to the frame 13 so that the membrane presents a relatively smooth pressure side surface. Stem 12 extends distally from the hub 16 and has a distal end 19 which has a flexible, J-shape bumper element 20 to provide a yielding engagement with a heart wall when deployed within a patient's heart chamber. The frame 13 and attached membrane 11 are collapsible toward the centerline axis 18 for delivery through a catheter.

The proximal or free ends 17 of ribs 14 are provided with sharp tip elements 21 which are configured to hold the frame 13 and the membrane 11 secured thereto in a deployed position within the patient's heart chamber. Preferably, the sharp tip elements 21 of the frame 13 penetrate into tissue of the patient's heart wall in order to secure the reinforced membrane 11 so as to partition the ventricular chamber in a desired manner.

As shown in FIG. 1, the stem 12 is provided with an inner lumen 22 for delivery of fluid to the non-operative portion of the ventricular chamber and discharge ports 23 are provided in the stem. The hub 16 is secured within the inner lumen 22 in the proximal end of stem 12 suitable means such as a friction fit, an adhesive bond or a pin. The hub 16 has a deployment pin 24 , as shown in FIG. 5, which as will be described later allows the partitioning device 10 to be deployed within the patient's heart chamber and released from a delivery system used to place the device. The distal ends of the reinforcing ribs 14 are secured to the hub 16 in a suitable manner. They may be secured to the surface defining the inner lumen or the hub may be provided with channels or bores in the wall of the hub into which the distal ends of the ribs may be secured. The ribs 14 are preshaped so that when not constrained (as shown in FIGS. 1 and 2), the free proximal ends 17 thereof expand to a desired angular displacement (θ) away from a center line axis 18 which is about 20° to about 90°, preferably about 50° to about 80°.

FIGS. 2-4 illustrate a suitable delivery system 30 with a partitioning component device 10 as shown in FIG. 1. The delivery system 30 includes a control handle 31 with a delivery catheter 32 having a deploying coil screw 33 secured to the distal end 34 for releasing the partitioning device 10 from the delivery system 30 . The delivery catheter 32 has a an inner lumen 35 through which therapeutic or diagnostic fluids may be delivered. The delivery catheter 32 extends through the handle 31 and the proximal end of the catheter 32 is secured to torquing knob 36 to allow rotation of the catheter by rotating knob 36 . An injection port 37 is provided in fluid communication with the delivery catheter 32 for injecting therapeutic or diagnostic fluids through the inner lumen 35 .

The delivery system 30 may be introduced into a patient's body through guiding catheter or cannula 40 which has an inner lumen 41 . A radiopaque marker (not shown) may be provided on the distal end of the guiding catheter 40 to aid in fluoroscopically guiding the catheter to the desired location. The partitioning device 10 is slidably disposed within the inner lumen 41 with the free proximal ends 17 of the ribs 14 in a constricted configuration. The guiding catheter 40 is percutaneously introduced in a conventional fashion into the patient's vasculature and advanced therein until the distal end 42 of the guiding catheter 40 is position close to the desired location for the partitioning device 10 within the patient's heart chamber such as the left ventricle. The delivery system 30 is advanced distally within the inner lumen 41 until the J-shaped bumper 20 extends out the distal end 42 of the guiding catheter 40 and engages the ventricular wall. With the delivery system 30 held in place and the bumper 20 engaging the ventricular wall, the guide catheter 40 is pulled proximally until the free ends 17 of ribs 14 are released from the distal end 42 so that anchoring tip elements 21 on the free proximal ends 17 of ribs 14 penetrate into tissue of the patient's heart wall as shown in FIG. 6 to secure the partitioning device 10 within the patient's heart chamber. With the partitioning device 10 properly positioned within the heart chamber, the delivery catheter 32 is rotated counter-clockwise to disengage the delivery system 30 from the hub 16 . Upon the counter-clockwise rotation of the delivery catheter 32 , the helical coil screw 33 attached to the distal end 34 of the delivery catheter 32 rides on the deployment pin 24 secured within the inner lumen 22 of the hub 16 . The delivery system 30 and the guide catheter 40 may then be removed from the patient. The proximal end of the guide catheter 40 is provided with an injection port 43 to inject therapeutic or diagnostic fluids through the inner lumen 41 .

FIG. 6 illustrates the placement of partitioning device 10 within a patient's left ventricle 45 . The membrane 11 secured to the proximal side of ribs 14 partitions the patient's heart chamber 45 into a main productive or operational portion 46 and a secondary, essentially non-productive portion 47 . The operational portion 46 is much smaller than the original ventricular chamber 45 and provides for an improved ejection fraction. The partitioning increases the ejection fraction and provides an improvement in blood flow. Over time, the non-productive portion 47 fills initially with thrombus and subsequently cellular growth. Bio-resorbable fillers such as polylactic acid, polyglycolic acid, polycaprolactone and copolymers and blends may be employed to fill the non-productive portion 47 . Fillers may be suitably supplied in a suitable solvent such as DMSO. Other materials which accelerate tissue growth may be deployed in the non-productive portion 47 .

FIGS. 7-12 illustrate distal ends 19 of the partitioning devices having alternative bumper elements for providing non-traumatic contact with a weakened ventricular wall. In FIG. 7 the distal end 19 of stem 12 has a pair of J-shaped bumpers 50 and 51 . In FIG. 8 the distal end 19 has three J-shaped bumpers 52 , 53 and 54 . FIG. 9 illustrates a distal end 19 having four J-shaped bumpers 55 , 56 , 57 and 58 . FIG. 10 depicts a slight change, where the distal end 19 has four wire J-shaped bumpers 59 - 62 with sharp tips 63 - 66 for securing the ends of the bumpers in heart tissue. A further alternative is illustrated in FIG. 11 where a membrane 68 is applied to the J-shaped bumpers In FIG. 12, the distal end 19 of stem 12 is provided with a coiled bumper 70 for engaging a ventricular wall.

Another modification is shown in FIG. 13 wherein an inflatable balloon 80 is provided on the distal side of the frame 13 to support and space the partitioning device 10 from a patient's ventricular wall in lieu of the stem with flexible bumpers, as shown in the partitioning devices previously described.

The ribs 14 of the partitioning device have a length of about 1 to about 8 cm, preferably, about 1.5 to about 4 cm for most left ventricle deployments. To assist in properly locating the device during advancement and placement thereof into a patient's heart chamber, the distal extremity of one or more of the ribs and/or the stem may be provided with markers at desirable locations that provide enhanced visualization by eye, by ultrasound, by X-ray, or other imaging or visualization means. Radiopaque markers may be made with, for example, stainless steel, platinum, gold, iridium, tantalum, tungsten, silver, rhodium, nickel, bismuth, other radiopaque metals, alloys and oxides of these metals.

The membrane 11 may be formed of suitable biocompatitble polymeric material which include ePTFE (expanded polytetrafluoroethylene), Nylon, PET (polyethylene terephthalate) and polyesters such as Hytrel. The membrane 11 is preferably foraminous in nature to facilitate tissue in growth after deployment within the patient's heart. The delivery catheter and the guiding catheter may be formed of suitable high strength polymeric material such as PEEK (polyetheretherketone), polycarbonate, PET, Nylon, and the like. Braided composite shafts may also be employed. To the extent not otherwise described herein, the various components of the partitioning device and delivery system may be formed of conventional materials and in a conventional manner as will be appreciated by those skilled in the art.

While particular forms of the invention have been illustrated and described herein, it will be apparent that various modifications and improvements can be made to the invention. Moreover, individual features of embodiments of the invention may be shown in some drawings and not in others, but those skilled in the art will recognize that individual features of one embodiment of the invention can be combined with any or all the features of another embodiment. Accordingly, it is not intended that the invention be limited to the specific embodiments illustrated. It is intended that this invention to be defined by the scope of the appended claims as broadly as the prior art will permit.

Terms such a “element”, “member”, “device”, “section”, “portion”, “steps”, “means” and words of similar import when used herein shall not be construed as invoking the provisions of 35 U.S.C. §112(6) unless the following claims expressly use the terms “means” followed by a particular function without specific structure or “step” followed by a particular function without specific action. All patents and patent applications referred to above are hereby incorporated by reference in their entirety. Accordingly, it is not intended that the invention be limited, except as by the appended claims.